What is Regen BioPharma, Inc. (RGBP) stock price today?

Regen BioPharma, Inc. (RGBP) is currently trading at $0.00.

What is RGBP P/E ratio?

Regen BioPharma, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is RGBP return on equity (ROE)?

Regen BioPharma, Inc.'s return on equity (ROE) is 16.67%, indicating how efficiently the company generates profit from shareholders' equity. This is above the market average.

What is Regen BioPharma, Inc.'s market cap?

Regen BioPharma, Inc. has a market capitalization of $3155.

OTC · Biotechnology

Regen BioPharma, Inc. (RGBP) Stock

$0.00 OTC: RGBP Healthcare

Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States.

Valuation

Metric	Value
Price	$0.00
Market Cap	$3155
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.22
EPS (TTM)	$-0.02
52-Week High	$0.05
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	16.67%
ROA	-252.85%
ROCE	16.22%
Gross Margin	100.00%
Operating Margin	-260.24%
Net Margin	0.00%
Debt/Equity	-0.17
Current Ratio	0.05

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$0	$0	$-1.0M	$0	$0
Net Profit	$-7.0M	$2.0M	$1.0M	$-1.0M	$-1.0M
EPS	$-1.69	$0.36	$0.14	$-0.16	$-0.05
Op Margin	-117.4%	-144.4%	-290.4%	-176.3%	-143.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.0M	$1.0M	$0	$0	$0
Total Liabilities	$15.0M	$9.0M	$5.0M	$5.0M	$7.0M
Cash	$1.0M	$0	$0	$0	$0
Borrowings	$4.0M	$1.0M	$1.0M	$1.0M	$1.0M

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-1.0M	$-1.0M	$0	$-1.0M	$0
Investing Cash Flow	$1.0M	$0	$0	$0	$0
Financing Cash Flow	$1.0M	$0	$0	$1.0M	$0
Net Cash Flow	$1.0M	$-1.0M	$0	$0	$0
Free Cash Flow	$-1.0M	$-1.0M	$0	$-1.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.75
FCF Yield	-15123.84%
Quick Ratio	0.05
Interest Coverage	-4.16
Return 1Y	-99.83%
Return 3Y	-99.99%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CBDGTHC Farmaceuticals, Inc.	$0.03	+0.00%	46.50	$505872	0.00%
CHNXFChitogenX Inc.	$0.01	+0.00%	-0.23	$627628	0.00%
DPATDental Patient Care America, Inc.	$0.04	+0.00%	1.74	$1.01M	0.00%
IPIXInnovation Pharmaceuticals Inc.	$0.00	—	-0.32	$1.04M	0.00%
LVTTFLevitee Labs Inc.	$0.00	—	-0.03	$369155	0.00%

About Regen BioPharma, Inc.

Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.

Regen BioPharma, Inc. (RGBP) stock trades at $0.00 with a market capitalization of $3155. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.22. Over the past 52 weeks the stock has ranged between $0.00 and $0.05, and currently trades 100.0% below its 52-week high.

On profitability, Regen BioPharma, Inc. generates a return on equity (ROE) of 16.67%, above the typical market average, return on capital employed of 16.22%, an operating margin of -260.24%, a net profit margin of 0.00%.

Official website: www.regenbiopharmainc.com